Hepatic Carcinoma

Explore clinical trials studying Hepatic Carcinoma. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Hepatic Carcinoma trial results

Completed

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

NCT03164382

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

View Trial Details

Completed

Arterial Base Fluorescence Segmental Positive Staining

NCT04266548

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Chang Gung Memorial Hospital Niaosong, Kaohsiung, Taiwan

View Trial Details

Completed

Endoscopic Ultrasound Guided Liver Biopsy

NCT03307811

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Center for Interventional Endoscopy - Florida Hospital Orlando, Florida, United States

View Trial Details

Completed

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy

NCT01770431

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Completed

Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).

NCT03163186

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

NCT00884520

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +35 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

NCT04220944

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Interventional Radiology, Zhongshan Hospital, Fudan University. Shanghai, Shanghai Municipality, China

View Trial Details

Hepatic Carcinoma

Hepatic Carcinoma trial results

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

Arterial Base Fluorescence Segmental Positive Staining

Endoscopic Ultrasound Guided Liver Biopsy

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy

Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

Related conditions